Orthofix Medical Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Massimo Calafiore
- Full Time Employees
- 1,605
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 3451 Plano Parkway Lewisville TX United States of America 75056
- IPO Date
- Apr 24, 1992
- CIK
- 0000884624
- Website
- orthofix.com
- Similar Companies
- Business
- Orthofix Medical Inc. (OFIX) develops, manufactures, and distributes medical devices and biologics focused on musculoskeletal healing. The company offers a comprehensive portfolio of products including spinal implant systems such as the M6-C and M6-L artificial cervical and lumbar discs, the Maestro and Ascentx systems for minimally invasive spine surgery; bone growth therapies like the Orthofix Bone Growth Therapy devices utilizing pulsed electromagnetic field technology; extremity fixation devices including the Fitbone intramedullary lengthening system and the TL-HEX circular external fixator; and regenerative biologics such as Osteocel cellular allografts and VersaShield synthetic bone void fillers. Orthofix serves orthopedic surgeons, neurosurgeons, and patients requiring treatment for spinal disorders, nonunion fractures, congenital deformities, and trauma through direct sales forces, independent distributors, and strategic partnerships. Founded in 1980 and headquartered in Lewisville, Texas, the company operates globally across North America, Europe, Asia-Pacific, and Latin America, with manufacturing facilities in the United States, Italy, and Mexico. In recent developments, Orthofix completed the acquisition of SeaSpine Holdings Corp in early 2023, significantly expanding its biologics and spinal implant offerings; launched the new Janusz posterior spinal correction system in late 2024; and entered a strategic distribution partnership with Zimmer Biomet for bone growth therapy devices in select international markets during 2025. [ from prior searches on company overview][ from recent changes search]
Company News
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook
Orthofix Medical Q2 Earnings Call Highlights
Orthofix Medical Inc. (OFIX) Q2 2026 Earnings Call Transcript
Bet on 5 Top-Ranked Stocks With Rising P/E
Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates
Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Wall Street Analysts Think Orthofix (OFIX) Could Surge 33.28%: Read This Before Placing a Bet
MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth
Orthofix to Participate in Upcoming Investor Conferences
Orthofix to Report Second Quarter 2026 Financial Results
Orthofix (OFIX) Moves 5.1% Higher: Will This Strength Last?
Orthofix Medical Inc. (OFIX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX)
Orthofix to Participate in Upcoming Investor Conferences